You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.6% | n/a |
| Div Cover | 8.4 | n/a |
| Op Mrgn | 2.2% | n/a |
| ROCE | 31.1% |
| Latest | Forecast | |
|---|---|---|
| P/E | 20.5 | n/a |
| PEG | -1.7 | n/a |
| Price / Revenue | 0.4 | n/a |
| Price / Book value | 3.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 9.5% | n/a |
| PBT | 26.7% | n/a |
| EPS | -11.9% | n/a |
| DPS | 105.5% | n/a |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 1,417.90 | 11.30 | €0.15 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 1,665.28 | 26.46 | €0.14 | 10.0 | -2.2 | -5% | €0.01 | 0.5% |
| 2020-12-31 | 1,823.85 | 33.53 | €0.13 | 22.2 | -1.9 | -12% | €0.02 | 0.5% |
| Uniphar ends year 'strong' as core divisions outperform Sharecast News | 02 Mar |
|---|---|
| Uniphar performs ahead of FY expectations Sharecast News | 27 Jan |
| Uniphar acquires US pharmaceutical advisory business Sharecast News | 24 Nov |
| Notice of AGM & Annual Report | 08-Apr-21 07:00 |
|---|---|
| Executive Restricted Share Plan Dealing | 04-Mar-21 07:30 |
| Director/PDMR Shareholding | 04-Mar-21 07:30 |
| 2020 Preliminary Results | 02-Mar-21 07:00 |
| Consent to Migration | 25-Feb-21 07:00 |